Clinical Trial Update: A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravenously administered Paxceed for rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Paxceed

Snippet

Sponsor: Angiotech Pharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED